Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles (2016 - 2018)

Ironwood Pharmaceuticals' Amortization - Intangibles history spans 3 years, with the latest figure at $1.2 million for Q3 2018.

  • For Q3 2018, Amortization - Intangibles fell 38.9% year-over-year to $1.2 million; the TTM value through Dec 2018 reached $8.1 million, up 30.53%, while the annual FY2018 figure was $8.1 million, 30.53% up from the prior year.
  • Amortization - Intangibles for Q3 2018 was $1.2 million at Ironwood Pharmaceuticals, down from $3.5 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $3.5 million in Q4 2017 and bottomed at -$3.3 million in Q4 2016.
  • The 3-year median for Amortization - Intangibles is $1.5 million (2017), against an average of $1.5 million.
  • The largest annual shift saw Amortization - Intangibles plummeted 60.47% in 2017 before it surged 727.62% in 2018.
  • A 3-year view of Amortization - Intangibles shows it stood at -$3.3 million in 2016, then surged by 205.43% to $3.5 million in 2017, then crashed by 66.66% to $1.2 million in 2018.
  • Per Business Quant, the three most recent readings for IRWD's Amortization - Intangibles are $1.2 million (Q3 2018), $3.5 million (Q2 2018), and $3.5 million (Q1 2018).